Jan Rietsema

📣 The recording of our last #Educational #webinar with Dr. Karolien Bijnens and Martijn Heleven on #planarians as an alternative in vivo model to assess developmental, neuro- 🧠 and genotoxicity 🧬 is now available! Check it out now via https://lnkd.in/enQityrj Stay tuned, our next webinar is coming soon 👀 #NAMs #3Rs #alternativeinvivo #knowledgesharing

12

Antimicrobial resistance and infection control in long-term care for intellectual disability   📝 Article: Mind the gap: knowledge, attitudes and perceptions on antimicrobial resistance, antimicrobial stewardship and infection prevention and control in long-term care facilities for people with disabilities in the Netherlands ✅ Published in: BMC ✏️ RIVM co-authors: Soemeja Hidad, Freek de Haan, Sabine De Greeff and Anja Haenen   📢 What is the reason for this publication? According to the World Health Organization, Antimicrobial resistance (AMR) has become a major public health threat. That is why adequate infection prevention and control (IPC) practices and intensified antimicrobial stewardship (AMS) are required to improve individual healthcare outcomes and reduce the introduction and transmission of resistant pathogens. This is particularly relevant for people with vulnerable health conditions, such as those with intellectual disabilities (ID). Public health initiatives, including IPC and AMS often overlook people with ID, despite their vulnerable health conditions. This research aimed to explore the knowledge, attitudes, perceptions, and practices towards AMR, IPC, and antimicrobial stewardship among Dutch healthcare professionals working in long-term care facilities for people with ID. The obtained insights can help to better tailor policies and practices for AMR, IPC and AMS among people with ID.   📤 What are the main outcomes? Healthcare professionals working in Dutch long-term care facilities for people with ID acknowledge the importance of IPC and AMR. Still, more attention needs to be given to adequate glove use. Moreover, current IPC guidelines are not always directly applicable to the ID sector, highlighting the need for tailored guidelines that align with daily practice. These tailored guidelines should target not only healthcare professionals but also people with ID themselves, to facilitate awareness, empower autonomy, and ensure that information about hygiene practices and IPC guidelines is accessible and understandable to all.   📈 What is the added value of this research from an international perspective? This publication sheds light on a group within our society that is often overlooked within health policy, both in the Netherlands and abroad. By conducting this research, we have gained insights into possible bottlenecks regarding AMR, IPC and AMS and provided recommendations that can be considered nationally and internationally to enhance AMR and IPC guidelines, IPC practices, and antimicrobial stewardship programmes in long-term care facilities for people with ID.   🔗 The scientific article can be read here: https://lnkd.in/eQBzhgaX #AMR #IPC #ID #AMS #healthcare #policies #longtermcare #publication

31

1 commentaar

🎉We are happy to share our new customer case study about kidney organoids with our microfluidic community. 🎉 🔬Menéndez et al.* from Erasmus University Medical Center (The Netherlands), published and presented in Scientific Reports (2022), a new model including Fluigent’s pressure pump for kidney organoid vascularization. Their findings revolutionized traditional methods using animal models. 🚀This novel organ-on-a-chip approach opens the door to new experiments and is promising for studying kidney development and diseases. 📖 Discover the entire customer case study: https://lnkd.in/gxzkSK7T Flow EZ: https://lnkd.in/gdDZUVpx #microfluidics #organoids #organonchip #kidney *Bas-Cristóbal Menéndez, A., Du, Z., van den Bosch, T.P.P. et al. Creating a kidney organoid-vasculature interaction model using a novel organ-on-chip system. Sci Rep 12, 20699 (2022). https://lnkd.in/gndSRsy8

9

🤖 Quicker detection of breast cancer by AI 🤖   Researchers from the UMC Utrecht, showed that AI pathologists can help to assess the sentinel node in breast cancer patients more efficiently. This assessment is necessary to detect potential metastasis of breast cancer.   Using AI for this detection makes the process more efficient, time saving and cheaper. The pathologists at UMC Utrecht are now working with the AI assistant as standard in breast cancer, probably as the first in the world.   You can read the whole publication in Nature Cancer via the link below 👇 https://lnkd.in/dg7TXn9W

18